30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Allakos Inc (ALLK)

Track

Stock chart
Ticker: ALLK Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Alexander Robert
Officer; Director
1 sale — total 8,021 USD
Proposed sale 6 Mar 2025
Value US$479,665.42 | Price 262.40 | Shares 16,450
Proposed sale 5 Mar 2025
Value US$17,052.29 | Price 248.96 | Shares 90,859
Proposed sale 5 Mar 2025
Value US$3,687.53 | Price 0.26 | Shares 14,161
Proposed sale 6 Dec 2024
Value US$23,219.15 | Price 1.10 | Shares 21,116
Proposed sale 6 Dec 2024
Value US$14,446.55 | Price 1.10 | Shares 13,138
Proposed sale 5 Dec 2024
Value US$35,764.55 | Price 1.10 | Shares 32,466
Proposed sale 4 Dec 2024
Value US$12,029.18 | Price 1.13 | Shares 10,634
Proposed sale 11 Sep 2024
Value US$21,804.54 | Price 0.58 | Shares 37,311
Proposed sale 9 Sep 2024
Value US$29,335.64 | Price 0.65 | Shares 45,320
Proposed sale 6 Sep 2024
Value US$8,808.45 | Price 0.64 | Shares 13,665
Proposed sale 6 Sep 2024
Value US$14,156.06 | Price 0.64 | Shares 21,961
Sale 28 Jun 2024
Value US$87,934.64 | Price 1.01 | Shares 87,064
Proposed sale 28 Jun 2024
Value US$87,857.12 | Price 1.01 | Shares 87,064
Proposed sale 7 Jun 2024
Value US$27,817.87 | Price 1.12 | Shares 24,749
Proposed sale 6 Jun 2024
Value US$42,849.80 | Price 1.14 | Shares 37,525
Proposed sale 4 Jun 2024
Value US$17,307.59 | Price 1.19 | Shares 14,565
Proposed sale 19 Mar 2024
Value US$19,897.43 | Price 1.26 | Shares 15,838
Proposed sale 6 Mar 2024
Value US$43,282.42 | Price 1.35 | Shares 32,142
Proposed sale 5 Mar 2024
Value US$68,315.57 | Price 1.44 | Shares 47,392
Proposed sale 4 Mar 2024
Value US$105,173.70 | Price 1.48 | Shares 70,910
Proposed sale 4 Dec 2023
Value US$61,840.42 | Price 2.50 | Shares 24,753
Proposed sale 4 Dec 2023
Value US$17,468.11 | Price 2.50 | Shares 6,992
Proposed sale 4 Dec 2023
Value US$20,935.76 | Price 2.50 | Shares 8,380
Proposed sale 4 Dec 2023
Value US$40,107.70 | Price 2.50 | Shares 16,054
Proposed sale 5 Sep 2023
Value US$23,900.22 | Price 3.01 | Shares 7,935
Proposed sale 5 Sep 2023
Value US$54,875.63 | Price 3.01 | Shares 18,219
Proposed sale 5 Sep 2023
Value US$84,625.16 | Price 3.01 | Shares 28,096
Proposed sale 5 Sep 2023
Value US$28,647.13 | Price 3.01 | Shares 9,511
Proposed sale 2 Jun 2023
Value US$135,619.90 | Price 5.13 | Shares 26,415
Proposed sale 2 Jun 2023
Value US$45,910.02 | Price 5.13 | Shares 8,942
Proposed sale 2 Jun 2023
Value US$38,301.13 | Price 5.13 | Shares 7,460
Proposed sale 2 Jun 2023
Value US$87,943.71 | Price 5.13 | Shares 17,129
Buy 21 Sep 2022
Value US$2,384,500.00 | Price 5.02 | Shares 475,000
Buy 21 Sep 2022
Value US$16,999,728.00 | Price 5.02 | Shares 3,386,400
Buy 21 Sep 2022
Value US$2,999,952.00 | Price 5.02 | Shares 597,600
Sale 28 Sep 2021
Value US$432,480.00 | Price 108.12 | Shares 4,000
Planned sale 15 Jun 2021
Value US$1,820,502.00 | Price 91.03 | Shares 20,000
Planned sale 14 Jun 2021
Value US$1,832,362.00 | Price 91.62 | Shares 20,000
Planned sale 7 Jun 2021
Value US$228,878.61 | Price 92.03 | Shares 2,487
Planned sale 4 Jun 2021
Value US$57,946.92 | Price 90.26 | Shares 642
Planned sale 4 Jun 2021
Value US$491,406.48 | Price 89.64 | Shares 5,482
Planned sale 4 Jun 2021
Value US$322,363.14 | Price 89.62 | Shares 3,597
Planned sale 4 Jun 2021
Value US$1,301,214.24 | Price 89.64 | Shares 14,516
Planned sale 3 Jun 2021
Value US$505,021.56 | Price 92.09 | Shares 5,484
Planned sale 3 Jun 2021
Value US$1,337,596.38 | Price 92.14 | Shares 14,517
Planned sale 2 Jun 2021
Value US$518,567.04 | Price 94.56 | Shares 5,484
Planned sale 2 Jun 2021
Value US$1,372,582.35 | Price 94.55 | Shares 14,517
Planned sale 19 May 2021
Value US$1,436,213.04 | Price 98.94 | Shares 14,516
Planned sale 18 May 2021
Value US$1,485,379.44 | Price 102.32 | Shares 14,517
Planned sale 17 May 2021
Value US$1,447,054.56 | Price 99.68 | Shares 14,517
Planned sale 12 May 2021
Value US$1,984,600.00 | Price 99.23 | Shares 20,000
Planned sale 11 May 2021
Value US$1,955,800.00 | Price 97.79 | Shares 20,000
Planned sale 10 May 2021
Value US$1,920,400.00 | Price 96.02 | Shares 20,000
Planned sale 14 Apr 2021
Value US$2,155,400.00 | Price 107.77 | Shares 20,000
Planned sale 13 Apr 2021
Value US$2,061,600.00 | Price 103.08 | Shares 20,000
Planned sale 12 Apr 2021
Value US$2,088,000.00 | Price 104.40 | Shares 20,000
Planned sale 6 Apr 2021
Value US$1,116,800.00 | Price 111.68 | Shares 10,000
Planned sale 5 Apr 2021
Value US$2,261,200.00 | Price 113.06 | Shares 20,000
Planned sale 1 Apr 2021
Value US$2,288,000.00 | Price 114.40 | Shares 20,000
Sale 26 Mar 2021
Value US$855,485.00 | Price 115.00 | Shares 7,439
Sale 26 Mar 2021
Value US$290,225.00 | Price 116.09 | Shares 2,500
Sale 26 Mar 2021
Value US$1,703,068.08 | Price 115.01 | Shares 14,808
Sale 22 Mar 2021
Value US$495,065.96 | Price 120.22 | Shares 4,118
Sale 22 Mar 2021
Value US$1,078,723.80 | Price 119.46 | Shares 9,030
Planned sale 17 Mar 2021
Value US$2,422,800.00 | Price 121.14 | Shares 20,000
Planned sale 16 Mar 2021
Value US$2,435,200.00 | Price 121.76 | Shares 20,000
Sale 16 Mar 2021
Value US$425,775.00 | Price 121.65 | Shares 3,500
Planned sale 15 Mar 2021
Value US$2,455,600.00 | Price 122.78 | Shares 20,000
Sale 15 Mar 2021
Value US$835,548.48 | Price 124.56 | Shares 6,708
Sale 12 Mar 2021
Value US$505,536.78 | Price 124.18 | Shares 4,071
Sale 11 Mar 2021
Value US$748,467.72 | Price 124.62 | Shares 6,006
Sale 11 Mar 2021
Value US$121,713.84 | Price 125.22 | Shares 972
Sale 11 Mar 2021
Value US$1,149,156.48 | Price 124.26 | Shares 9,248
Sale 11 Mar 2021
Value US$1,238,234.23 | Price 123.49 | Shares 10,027
Sale 10 Mar 2021
Value US$262,047.59 | Price 124.37 | Shares 2,107
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-06 2025-03-06 PrS Proposed sale
Alexander Robert

Officer; Director

Executive Director
16,450
262.40
US$479,665 		16,450 262.40 US$479,665
2025-03-05 2025-03-05 PrS Proposed sale
Tomasi Adam

Officer

Officer
90,859
248.96
US$17,052 		90,859 248.96 US$17,052
2025-03-05 2025-03-05 PrS Proposed sale
2.3
Radford Harlan Baird

Officer

Officer
55,858
496.45
US$2,247,078 		55,858 496.45 US$2,247,078
2024-12-06 2024-12-06 PrS Proposed sale
Tomasi Adam

Officer

Officer
21,116
1.10
US$23,219 		21,116 1.10 US$23,219
2024-12-06 2024-12-06 PrS Proposed sale
2.3
Radford Harlan Baird

Officer

Officer
13,138
1.10
US$14,447 		13,138 1.10 US$14,447
2024-12-05 2024-12-05 PrS Proposed sale
Alexander Robert

Officer; Director

Executive Director
32,466
1.10
US$35,765 		32,466 1.10 US$35,765
2024-12-04 2024-12-04 PrS Proposed sale
Lee Chin Hyok

Officer

Officer
10,634
1.13
US$12,029 		10,634 1.13 US$12,029
2024-09-11 2024-09-11 PrS Proposed sale
Alexander Robert

Officer; Director

Executive Director
37,311
0.58
US$21,805 		37,311 0.58 US$21,805
2024-09-09 2024-09-09 PrS Proposed sale
Lee Chin Hyok

Officer

Officer
45,320
0.65
US$29,336 		45,320 0.65 US$29,336
2024-09-06 2024-09-06 PrS Proposed sale
2.3
Radford Harlan Baird

Officer

Officer
13,665
0.64
US$8,808 		13,665 0.64 US$8,808
2024-09-06 2024-09-06 PrS Proposed sale
Tomasi Adam

Officer

Officer
21,961
0.64
US$14,156 		21,961 0.64 US$14,156
2024-07-02 2024-06-28 S Sale
2.3
Radford Harlan Baird

Chief Financial Officer

Officer
87,064 -29.9%
1.01
US$87,935 		87,064 -29.9% 1.01 US$87,935
2024-06-28 2024-06-28 PrS Proposed sale
2.3
Radford Harlan Baird

Officer

Officer
87,064
1.01
US$87,857 		87,064 1.01 US$87,857
2024-06-07 2024-06-07 PrS Proposed sale
Tomasi Adam

Officer

Officer
24,749
1.12
US$27,818 		24,749 1.12 US$27,818
2024-06-06 2024-06-06 PrS Proposed sale
Alexander Robert

Officer; Director

Executive Director
37,525
1.14
US$42,850 		37,525 1.14 US$42,850
2024-06-04 2024-06-04 PrS Proposed sale
2.3
Radford Harlan Baird

Officer

Officer
14,565
1.19
US$17,308 		14,565 1.19 US$17,308
2024-03-19 2024-03-19 PrS Proposed sale
Paterson Craig A.

Former Officer

Officer
15,838
1.26
US$19,897 		15,838 1.26 US$19,897
2024-03-06 2024-03-06 PrS Proposed sale
2.3
Radford Harlan Baird

Officer

Officer
32,142
1.35
US$43,282 		32,142 1.35 US$43,282
2024-03-05 2024-03-05 PrS Proposed sale
Tomasi Adam

Officer

Officer
47,392
1.44
US$68,316 		47,392 1.44 US$68,316
2024-03-04 2024-03-04 PrS Proposed sale
Alexander Robert

Officer; Director

Executive Director
70,910
1.48
US$105,174 		70,910 1.48 US$105,174
2023-12-04 2023-12-04 PrS Proposed sale
Alexander Robert

Officer; Director

Executive Director
24,753
2.50
US$61,840 		24,753 2.50 US$61,840
2023-12-04 2023-12-04 PrS Proposed sale
Paterson Craig A.

Officer

Officer
6,992
2.50
US$17,468 		6,992 2.50 US$17,468
2023-12-04 2023-12-04 PrS Proposed sale
2.3
Radford Harlan Baird

Officer

Officer
8,380
2.50
US$20,936 		8,380 2.50 US$20,936
2023-12-04 2023-12-04 PrS Proposed sale
Tomasi Adam

Officer

Officer
16,054
2.50
US$40,108 		16,054 2.50 US$40,108
2023-09-05 2023-09-05 PrS Proposed sale
Paterson Craig A.

Officer

Officer
7,935
3.01
US$23,900 		7,935 3.01 US$23,900
2023-09-05 2023-09-05 PrS Proposed sale
Tomasi Adam

Officer

Officer
18,219
3.01
US$54,876 		18,219 3.01 US$54,876
2023-09-05 2023-09-05 PrS Proposed sale
Alexander Robert

Officer; Director

Executive Director
28,096
3.01
US$84,625 		28,096 3.01 US$84,625
2023-09-05 2023-09-05 PrS Proposed sale
2.3
Radford Harlan Baird

Officer

Officer
9,511
3.01
US$28,647 		9,511 3.01 US$28,647
2023-06-02 2023-06-02 PrS Proposed sale
Alexander Robert

Officer; Director

Executive Director
26,415
5.13
US$135,620 		26,415 5.13 US$135,620
2023-06-02 2023-06-02 PrS Proposed sale
2.3
Radford Harlan Baird

Officer

Officer
8,942
5.13
US$45,910 		8,942 5.13 US$45,910
2023-06-02 2023-06-02 PrS Proposed sale
Paterson Craig A.

Officer

Officer
7,460
5.13
US$38,301 		7,460 5.13 US$38,301
2023-06-02 2023-06-02 PrS Proposed sale
Tomasi Adam

Officer

Officer
17,129
5.13
US$87,944 		17,129 5.13 US$87,944
2022-09-23 2022-09-21 B Purchase
3.6
JANNEY DANIEL
Non-Executive Director Large shareholder
475,000 +22.9%
5.02
US$2,384,500 		475,000 +22.9% 5.02 US$2,384,500
2022-09-23 2022-09-21 B Purchase
3.9
Walker Paul Edward
Non-Executive Director
3,386,400 +inf%
5.02
US$16,999,728 		3,386,400 +inf% 5.02 US$16,999,728
2022-09-23 2022-09-21 B Purchase
3.9
Walker Paul Edward
Non-Executive Director
597,600 +27.6%
5.02
US$2,999,952 		597,600 +27.6% 5.02 US$2,999,952
2021-09-29 2021-09-28 S Sale
3.7
James Steven P
Non-Executive Director
4,000 -100.0%
108.12
US$432,480 		4,000 -100.0% 108.12 US$432,480
2021-06-16 2021-06-15 PlS Planned sale
Tomasi Adam

President and COO

Officer
20,000 -11.9%
91.03
US$1,820,502 		20,000 -11.9% 91.03 US$1,820,502
2021-06-16 2021-06-14 PlS Planned sale
Tomasi Adam

President and COO

Officer
20,000 -11.9%
91.62
US$1,832,362 		20,000 -11.9% 91.62 US$1,832,362
2021-06-07 2021-06-07 PlS Planned sale
Tomasi Adam

President and COO

Officer
2,487 -1.7%
92.03
US$228,879 		2,487 -1.7% 92.03 US$228,879
2021-06-07 2021-06-04 PlS Planned sale
Tomasi Adam

President and COO

Officer
642 -0.4%
90.26
US$57,947 		642 -0.4% 90.26 US$57,947
2021-06-04 2021-06-04 PlS Planned sale
Alexander Robert

Chief Executive Officer

Executive Director
5,482 -1.7%
89.64
US$491,406 		5,482 -1.7% 89.64 US$491,406
2021-06-04 2021-06-04 PlS Planned sale
Alexander Robert

Chief Executive Officer

Executive Director
3,597 -1.5%
89.62
US$322,363 		3,597 -1.5% 89.62 US$322,363
2021-06-04 2021-06-04 PlS Planned sale
Alexander Robert

Chief Executive Officer

Executive Director
14,516 -5.8%
89.64
US$1,301,214 		14,516 -5.8% 89.64 US$1,301,214
2021-06-04 2021-06-03 PlS Planned sale
Alexander Robert

Chief Executive Officer

Executive Director
5,484 -1.7%
92.09
US$505,022 		5,484 -1.7% 92.09 US$505,022
2021-06-04 2021-06-03 PlS Planned sale
Alexander Robert

Chief Executive Officer

Executive Director
14,517 -5.6%
92.14
US$1,337,596 		14,517 -5.6% 92.14 US$1,337,596
2021-06-04 2021-06-02 PlS Planned sale
Alexander Robert

Chief Executive Officer

Executive Director
5,484 -1.6%
94.56
US$518,567 		5,484 -1.6% 94.56 US$518,567
2021-06-04 2021-06-02 PlS Planned sale
Alexander Robert

Chief Executive Officer

Executive Director
14,517 -5.6%
94.55
US$1,372,582 		14,517 -5.6% 94.55 US$1,372,582
2021-05-19 2021-05-19 PlS Planned sale
Alexander Robert

Chief Executive Officer

Executive Director
14,516 -5.6%
98.94
US$1,436,213 		14,516 -5.6% 98.94 US$1,436,213
2021-05-19 2021-05-18 PlS Planned sale
Alexander Robert

Chief Executive Officer

Executive Director
14,517 -5.6%
102.32
US$1,485,379 		14,517 -5.6% 102.32 US$1,485,379
2021-05-19 2021-05-17 PlS Planned sale
Alexander Robert

Chief Executive Officer

Executive Director
14,517 -5.6%
99.68
US$1,447,055 		14,517 -5.6% 99.68 US$1,447,055
2021-05-13 2021-05-12 PlS Planned sale
Tomasi Adam

President and COO

Officer
20,000 -11.6%
99.23
US$1,984,600 		20,000 -11.6% 99.23 US$1,984,600
2021-05-13 2021-05-11 PlS Planned sale
Tomasi Adam

President and COO

Officer
20,000 -11.6%
97.79
US$1,955,800 		20,000 -11.6% 97.79 US$1,955,800
2021-05-13 2021-05-10 PlS Planned sale
Tomasi Adam

President and COO

Officer
20,000 -11.6%
96.02
US$1,920,400 		20,000 -11.6% 96.02 US$1,920,400
2021-04-14 2021-04-14 PlS Planned sale
Tomasi Adam

President, COO and CFO

Officer
20,000 -11.6%
107.77
US$2,155,400 		20,000 -11.6% 107.77 US$2,155,400
2021-04-14 2021-04-13 PlS Planned sale
Tomasi Adam

President, COO and CFO

Officer
20,000 -11.6%
103.08
US$2,061,600 		20,000 -11.6% 103.08 US$2,061,600
2021-04-14 2021-04-12 PlS Planned sale
Tomasi Adam

President, COO and CFO

Officer
20,000 -11.6%
104.40
US$2,088,000 		20,000 -11.6% 104.40 US$2,088,000
2021-04-06 2021-04-06 PlS Planned sale
RASMUSSEN HENRIK S MD

Chief Medical Officer

Officer
10,000 -8.9%
111.68
US$1,116,800 		10,000 -8.9% 111.68 US$1,116,800
2021-04-06 2021-04-05 PlS Planned sale
RASMUSSEN HENRIK S MD

Chief Medical Officer

Officer
20,000 -16.4%
113.06
US$2,261,200 		20,000 -16.4% 113.06 US$2,261,200
2021-04-06 2021-04-01 PlS Planned sale
RASMUSSEN HENRIK S MD

Chief Medical Officer

Officer
20,000 -16.4%
114.40
US$2,288,000 		20,000 -16.4% 114.40 US$2,288,000
2021-03-30 2021-03-26 S Sale
1.9
MCKEARN JOHN P
Non-Executive Director
7,439 -86.1%
115.00
US$855,485 		7,439 -86.1% 115.00 US$855,485
2021-03-30 2021-03-26 S Sale
3.6
JANNEY DANIEL
Non-Executive Director Large shareholder
2,500 -4.3%
116.09
US$290,225 		2,500 -4.3% 116.09 US$290,225
2021-03-30 2021-03-26 S Sale
3.6
JANNEY DANIEL
Non-Executive Director Large shareholder
14,808 -20.1%
115.01
US$1,703,068 		14,808 -20.1% 115.01 US$1,703,068
2021-03-24 2021-03-22 S Sale
3.6
JANNEY DANIEL
Non-Executive Director Large shareholder
4,118 -5.3%
120.22
US$495,066 		4,118 -5.3% 120.22 US$495,066
2021-03-24 2021-03-22 S Sale
3.6
JANNEY DANIEL
Non-Executive Director Large shareholder
9,030 -10.4%
119.46
US$1,078,724 		9,030 -10.4% 119.46 US$1,078,724
2021-03-17 2021-03-17 PlS Planned sale
Alexander Robert

Chief Executive Officer

Executive Director
20,000 -7.5%
121.14
US$2,422,800 		20,000 -7.5% 121.14 US$2,422,800
2021-03-17 2021-03-16 PlS Planned sale
Alexander Robert

Chief Executive Officer

Executive Director
20,000 -7.5%
121.76
US$2,435,200 		20,000 -7.5% 121.76 US$2,435,200
2021-03-17 2021-03-16 S Sale
3.7
James Steven P
Non-Executive Director
3,500 -100.0%
121.65
US$425,775 		3,500 -100.0% 121.65 US$425,775
2021-03-17 2021-03-15 PlS Planned sale
Alexander Robert

Chief Executive Officer

Executive Director
20,000 -7.5%
122.78
US$2,455,600 		20,000 -7.5% 122.78 US$2,455,600
2021-03-16 2021-03-15 S Sale
3.6
JANNEY DANIEL
Non-Executive Director Large shareholder
6,708 -7.2%
124.56
US$835,548 		6,708 -7.2% 124.56 US$835,548
2021-03-16 2021-03-12 S Sale
3.6
JANNEY DANIEL
Non-Executive Director Large shareholder
4,071 -4.2%
124.18
US$505,537 		4,071 -4.2% 124.18 US$505,537
2021-03-11 2021-03-11 S Sale
3.6
JANNEY DANIEL
Non-Executive Director Large shareholder
6,006 -5.8%
124.62
US$748,468 		6,006 -5.8% 124.62 US$748,468
2021-03-11 2021-03-11 S Sale
3.5
Hudson Peter A

member - potential 10% group
972 -10.8%
125.22
US$121,714 		972 -10.8% 125.22 US$121,714
2021-03-11 2021-03-11 S Sale
3.5
Hudson Peter A

member - potential 10% group
9,248 -50.8%
124.26
US$1,149,156 		9,248 -50.8% 124.26 US$1,149,156
2021-03-11 2021-03-11 S Sale
3.5
Hudson Peter A

member - potential 10% group
10,027 -35.5%
123.49
US$1,238,234 		10,027 -35.5% 123.49 US$1,238,234
2021-03-11 2021-03-10 S Sale
3.5
Hudson Peter A

member - potential 10% group
2,107 -6.9%
124.37
US$262,048 		2,107 -6.9% 124.37 US$262,048
Explore more

More insider trading research around Allakos Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America